Showing results (11-20 of 344) with videos related to
Sort By:
Pageof 35
International Journal of Cancer|April 10, 2009
Expression of the ULBP ligands for NKG2D by B-NHL cells plays an important role in determining their susceptibility to rituximab-induced ADCCAtsushi Inagaki, Takashi Ishida, Hiroki Yano, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 18, 2010
Defucosylated humanized anti-CCR4 monoclonal antibody KW-0761 as a novel immunotherapeutic agent for adult T-cell leukemia/lymphomaToshihiko Ishii, Takashi Ishida, Atae Utsunomiya, et al.Japanese Journal of Clinical Oncology|December 5, 2021
Symptoms and health-related quality of life in patients with newly diagnosed multiple myeloma: a multicenter prospective cohort studyNana Suzuki, Toru Okuyama, Tatsuo Akechi, et al.Blood|June 2, 2009
The Asn505 mutation of the c-MPL gene, which causes familial essential thrombocythemia, induces autonomous homodimerization of the c-Mpl protein due to strong amino acid polarityJianmin Ding, Hirokazu Komatsu, Shinsuke Iida, et al.International Journal of Hematology|March 18, 2019
Pre- and post-transplant ponatinib for a patient with acute megakaryoblastic blast phase chronic myeloid leukemia with T315I mutation who underwent allogeneic hematopoietic stem cell transplantationHirokazu Sasaki, Sachiko Mitani, Shigeru Kusumoto, et al.Yakugaku Zasshi : Journal of the Pharmaceutical Society of Japan|May 8, 2015
[Development of mogamulizumab and establishment of an optimal therapy based on genomic biomarkers: from the academic viewpoint]Shinsuke Iida, Takashi Ishida, Ryuzo UedaCancer Immunology, Immunotherapy : CII|December 3, 2008
Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse modelAsahi Ito, Takashi Ishida, Hiroki Yano, et al.Journal of Immunology (Baltimore, Md. : 1950)|September 15, 2009
Defucosylated anti-CCR4 monoclonal antibody exerts potent ADCC against primary ATLL cells mediated by autologous human immune cells in NOD/Shi-scid, IL-2R gamma(null) mice in vivoAsahi Ito, Takashi Ishida, Atae Utsunomiya, et al.Haematologica|January 19, 2007
Induction of class II major histocompatibility complex expression in human multiple myeloma cells by retinoidTakaomi Sanda, Shinsuke Iida, Satoshi Kayukawa, et al.Japanese Journal of Clinical Oncology|July 13, 2022
Recent advances in the management of older adults with newly diagnosed multiple myeloma in JapanTomotaka Suzuki, Dai Maruyama, Shinsuke Iida, et al.Pageof 35